http://dx.doi.org/10.15279/kpba.2015.20. 4.175 cating EGF and EGFR signaling pathways that regulate or mediate the epithelial-to-mesenchymal transition (EMT) in the development of CC. 6, 7 However, reduced EGFR expression and activation was shown to correlate with a lack of differentiation in CC, even in CC with an altered EMT. 8 The molecular mechanism underlying tumor progression, by which tumor cells acquire the phenotypes of invasiveness and metastasis, is therefore still unclear in CC.
The current chemotherapy regimen that is used to treat CC has very limited benefit in terms of patient survival. Sarcomatoid (SC) CC is predominantly composed of spindle cells, giant cells, and bizarre cells and is believed to have an epithelial origin with transformation to the sarcomatous type. The sarcomatoid change in CC, referred to as the EMT, contributes to a more aggressive intrahepatic spread and widespread metastasis, and CC with a sarcomatoid change has a poorer prognosis than ordinary CC.
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GENOME-WIDE EXPRESSION PATTERNS ASSOCIATED WITH ONCOGENESIS AND SARCOMATOUS TRANSDIFFERENTATION OF CHOLANGIOCARCINOMA
Gene expression patterns distinguish CC cells from cultured normal biliary epithelial (NBE) cells
Using BeadChip microarray analysis, we compared the gene expression profiles of nine CC cell lines, an immortalized biliary epithelial cell line, and four types of NBE cells.
We selected 828 unique genes with a 2-fold or greater expression difference from the mean, with a p < 0.01 by t -test.
Unsupervised hierarchical clustering analysis of all samples was based on the similarity in the expression pattern of all genes ( Fig. 1 ). Cell samples were separated into two main groups, the NBE cluster, and the transformed and immor- Unsupervised hierarchical clustering separated the samples into two main groups, normal biliary epithelial (NBE) cells isolated from mucosal slices of normal bile ducts and ex-vivo cultured as described in Methods, and cholangiocarcinoma cells (CCC). Data are in matrix format, with columns representing individual cell lines and rows representing each gene. Red, high expression; green, low expression; black, no significant change in expression level between the mean and sample. A hierarchical clustering algorithm was applied to all cells and genes using the 1 -Pearson correlation coefficient as a similarity measure. Raw data for a single array were summarized using Illumina BeadStudio v3.0 and output to the user was as a set of 43,148 values for each individual hybridization. We selected 828 unique genes with a two-fold or greater difference from the mean and p < 0.01 by t-test, for hierarchical clustering analysis. Specific gene clusters (Cluster 1 through Cluster III) were identified in the hierarchical cluster of the genes differentially expressed in CCC compared with NBE. CC, cholangiocarcinoma; IMC, immortalized cholangiocytes. 
Gene expression patterns distinguish CC tissues from cultured NBE cells

Differential expression and verification of CCrelated genes
We compared the gene lists from the cell-based and tissue-based databases, and selected 342 commonly regulated genes, including 53 commonly upregulated genes and 289 commonly downregulated genes (Fig. 3A) . To verify the microarray data, we examined the mRNA levels of the identified genes using real-time reverse transcription polymerase (Fig. 4C, left) . In contrast, LCN2, EGF effectively reduced the levels of EGFR and ANXA8 promoter activity to 61% and 43% of vehicle controls, respectively (p = .005) (Fig. 5D ).
Transcriptional Regulation of ANXA8 by FOXO4
Insulin or growth factor inhibits the transcriptional activi- Akt and Act-Akt, whereas TMFOXO4, with 3 mutated phosphorylation sites, ie, T28A, S193A, and S258A, did not serve as a substrate (Fig. 6B) . EGF increased the PI3K/Aktinduced phosphorylation of FOXO4 in the cytoplasm and simultaneously decreased the nuclear translocation of FOXO4 and subsequent down-regulation of ANXA8 expression, which was inhibited by the PI3K inhibitor wortmannin (Fig. 6C) . The TM-FOXO4 increased the luciferase activity up to 5.3-fold, and the mutant of FOXO4, which lacks the DNA-binding domain, decreased the luciferase activity by half, as compared with WT-Akt (Fig. 6D ). These findings suggest that FOXO4 and its phosphorylation can positively and negatively regulate ANXA8 promoter activity, respectively. The immunofluorescence data confirm that the ectopically expressed wild-type FOXO4 can translocalize to the nucleus with or without ANXA8 induction, whereas the TM-FOXO4 easily translocates to the nucleus and always induces the expression of ANXA8 (Fig. 6E ).
ANXA8 Inhibits the Migratory and Metastatic Characteristics of CC Cells
The parental SCK cells and vector control cells (VC1 and VC3) readily penetrated the matrix and colonized the bottom surface of the Matrigel-coated membrane (a modified Boyden chamber assay), whereas the stable transfectants that expressed ANXA8 rarely showed this behavior ( produced no mortality until 80 days after intraperitoneal inoculation (Fig. 7B) . A necropsy revealed that the parental cells or the vector control cells extensively colonized the visceral organs and formed multiple metastatic masses with bloody ascites. In contrast, the stable ANXA8 transfectants first colonized and then continued growing into the peritoneum with only rare metastatic nodules (Fig. 7C ).
In conclusion, ANXA8 is transcriptionally down-regulated by EGF-mediated FOXO4 phosphorylation and that the subsequent deregulation of FAK and F-actin dunamics is responsible for the morphology of EMT. Therefore, ANXA8 is functionally related to tumorigenesis, whereas its down-regulation is essential for tumor progression and metastasis. (Fig. 8C, upper panels) . Therefore, EGF seems to transcriptionally regulate EphA2 and EFNA1. The EGF-mediated morphological changes were consistent with EMT changes (Fig. 8D ), as we previously described. Among the cells treated with various growth factors, the promoter activity of EphA2 was highest in the EGFtreated cells (Fig. 8E) . EGF dose-dependently induced EphA2 overexpression and phosphorylation on S897, but not on Y594 (Fig. 8F) . These results suggest that aberrant expression of EphA2 resulting from abnormal growth factor 
ACTIVATION OF MAMMALIAN TARGET
Morphological Changes Caused by EphA2
Overexpression of EphA2 is correlated with disease progression and highly malignant cellular phenotypes. We at Y594 (Fig. 9C) . The cell morphology changed from fibroblastoid type to epitheloid type, i.e., reverse EMT (mesenchymal-eipthelial trasition) (Fig. 9D) . Alternatively, we ex- (Fig. 9E ).
Enhanced Tumorigenicity of EphA2
In order to determine if human EphA2 has pro-oncogenic properties, the capacity of EphA2 to anchor independent cell growth was compared to vector control cells by determining the level of colony growth on soft agar. The stable EphA2 transfectants formed a greater number of larger colonies on soft agar (Fig. 10A) . Furthermore, tumor growth (Fig. 10B) . These results suggest that EphA2 plays a crucial role in tumor growth in vitro and in vivo . In addition, intrahepatic tumor metastases were more enhanced in orthotopic xenoplants from the stable EphA2 transfectants than from the vector control cells.
Migratory and Metastatic Abilities Induced by EphA2
The EMT of epithelial cancers is correlated with aggressive tumors that are believed to play a critical role in metastatic cancer. We therefore examined whether EphA2 overexpression contributed to tumor invasiveness and metastasis by affecting the EMT phenomena in CC cells. We found that adhesion molecules such as E-cadherin and desmoplakin I/II were down-regulated, and locomotion molecules, including fibronectin, vimentin (VIM), N-cadherin, and alpha smooth muscle actin, were up-regulated in the cells stably expressing EphA2 (Fig. 11A) . Wound repair assays were performed on Cho-CK cells stably expressing EphA2, and the stable transfectants demonstrated a visibly enhanced capacity to migrate into the wounded area compared to the vector control cells (Fig. 11B) . In a modified Boyden cham- ber assay, the stable transfectants readily penetrated the matrix and colonized the bottom surface of the Matrigelcoated membrane, while the vector control cells did not (Fig. 11C) . (black arrowhead) than were achieved with the vector control cells (Fig. 11D) . A histocytological examination confirmed these results (Fig. 11E ). Many metastatic nodules strongly expressed EphA2 in the lungs.
Downstream Signaling of EphA2
Next, we sought to identify the phosphorylation of downstream molecules using Human Phospho-Kinase Arrays (Fig. 12A ). EphA2 overexpression led to phosphorylation of 12C ). EphA2 overexpression also led to c-Src phosphorylation (Fig. 12D) . The knockdown experiments revealed that EphA2 knockdown itself resulted in EFNA1 induction and was linked to the inhibition of canonical upstream activators of ERK signaling, including b/c-Raf and MEK (Fig. 12E) . (Fig. 13A) . The Matrigel-coated transwell invasion assay similarly showed that PP2 completely inhibited invasion of Matrigel pores, while rapamycin provided only partial inhibition (Fig. 13B) . These results suggest that the Akt/ mTORC1 pathway plays a major role in regulating cell proliferation while the Pyk2/c-Src pathway generally acts to modulate metastatic ability. However, the Akt/mTOR and Pyk2/c-Src pathways also appeared to substantially influence each other. We further examined the morphological changes occurring in the stable transfectants expressing EphA2 after rapamycin or PP2 treatment. Rapamycin partially inhibited the migratory characteristics and stress fiber formation, while PP2 completely suppressed these phenomena (Fig.   13C ).
To exclude the cell-specific function of EphA2 we used metastasis-prone CC cells, JCK, to determine whether EphA2 expression is critical for metastasis of CC cells because these cells express high levels of EphA2. EphA2 
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